Itolizumab (rDNA origin) has now been granted Restricted Emergency Use authorisation by the Drugs Controller General of India (DCGI) based on clinical trials data. It is a monoclonal antibody which was already approved for severe chronic plaque psoriasis. Daily Current Affairs Quiz 2020 ...
READ MORE +